ALZN vs NTRS · $2.4M cap vs P/E 18, rev $2.69B
Alzamend Neuro Inc (ALZN) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
ALZN does not have a complete income-statement cache yet.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
ALZN currently screens at market cap $2.4M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the ALZN and NTRS stock pages for the full models.
Not investment advice.